| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |